首页> 外国专利> TRIAZOLOQUINAZOLINE AND PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL, COMPOSITION ADENOSINE A3 RECEPTOR AFFINITIVE AGENT, INTRAOCULAR-PRESSURE REDUCING AGENT, PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF GLAUCOMA, AND INTRAOCULAR-PRESSURE REDUCING METHOD

TRIAZOLOQUINAZOLINE AND PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL, COMPOSITION ADENOSINE A3 RECEPTOR AFFINITIVE AGENT, INTRAOCULAR-PRESSURE REDUCING AGENT, PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF GLAUCOMA, AND INTRAOCULAR-PRESSURE REDUCING METHOD

机译:噻唑并喹唑啉和吡唑并三唑并嘧啶衍生物,药物,组成腺嘌呤A3受体的辅助剂,眼内降压剂,预防和治疗青光眼的药物制备及方法

摘要

Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives represented bythe following general formula (1): (1) wherein R1 and R2 are each as definedin the description; and A represents a pyrazole or benzene ring optionallysubstituted by the group as cited in the description. These derivatives showan affinity for adenosine A3 receptor and an effect of lowering oculartension, which makes them useful in preventing or treating glaucoma.
机译:代表的三唑并喹唑啉和吡唑并三唑并嘧啶衍生物下列通式(1):(1)其中R1和R2各自定义在描述中; A表示吡唑或苯环,任选地由说明书中引用的基团取代。这些衍生品显示对腺苷A3受体的亲和力和降低眼睛的作用张力,使它们可用于预防或治疗青光眼。

著录项

  • 公开/公告号CA2437437A1

    专利类型

  • 公开/公告日2002-08-15

    原文格式PDF

  • 申请/专利权人 OTSUKA PHARMACEUTICAL FACTORY INC.;

    申请/专利号CA20022437437

  • 申请日2002-02-01

  • 分类号C07D487/14;A61P29/00;A61P43/00;A61P35/02;C07D487/04;A61P17/04;A61P11/06;A61P27/06;A61P37/08;A61P9/10;A61P11/10;A61P9/12;A61P11/14;A61K31/519;

  • 国家 CA

  • 入库时间 2022-08-22 00:40:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号